ImClone Investigational Site

Cleveland, Ohio 44195

0 studies enrolling now · 9 studies all time

What they study most

Advanced Solid Tumors, Colorectal Cancer, Colorectal Neoplasms, Malignant Solid Tumor, Metastatic Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Prostate Cancer, Sarcoma, Soft Tissue

Studies at this site

• A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors — Completed
• A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study of Olaratumab in Soft Tissue Sarcoma — Completed
• A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors — Completed
• A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer — Completed
• A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma — Completed
• Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy — Completed
• Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer — Completed
• A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer — Completed